Proteolytic cleavage of Ser52Pro variant transthyretin triggers its amyloid fibrillogenesis
about
Historical and Current Concepts of Fibrillogenesis and In vivo Amyloidogenesis: Implications of Amyloid Tissue TargetingMechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin AmyloidosisCommon Fibril Structures Imply Systemically Conserved Protein Misfolding Pathways In Vivo.Systemic amyloidosis: lessons from β2-microglobulin.Inhibition of the mechano-enzymatic amyloidogenesis of transthyretin: role of ligand affinity, binding cooperativity and occupancy of the inner channel.An overview of drugs currently under investigation for the treatment of transthyretin-related hereditary amyloidosis.Noncerebral Amyloidoses: Aspects on Seeding, Cross-Seeding, and Transmission.A novel mechano-enzymatic cleavage mechanism underlies transthyretin amyloidogenesis.(99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosisCo-fibrillogenesis of Wild-type and D76N β2-Microglobulin: THE CRUCIAL ROLE OF FIBRILLAR SEEDS.Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.Advances in proteomic study of cardiac amyloidosis: progress and potential.One mutation, two distinct disease variants: unravelling the impact of transthyretin amyloid fibril composition.Peptide probes detect misfolded transthyretin oligomers in plasma of hereditary amyloidosis patients.Systemic amyloidoses and proteomics: The state of the art.Targeting Amyloid Aggregation: An Overview of Strategies and MechanismsPlasminogen activation triggers transthyretin amyloidogenesisA FTIR microspectroscopy study of the structural and biochemical perturbations induced by natively folded and aggregated transthyretin in HL-1 cardiomyocytes
P2860
Q26744469-76187898-7A31-43CD-83F4-FA70F12A1698Q26764754-7C95D89A-4589-4230-AF63-19B53764CDFFQ30313147-334E18F3-F94F-43F7-B287-991877C2433FQ30372510-C3765E7A-0292-47DE-9958-8E8B1FAF272FQ33671132-624DCE47-3382-4A87-BB42-E32C0962A54EQ34428314-CCE0522E-243F-4744-B601-C96D11B0F337Q34549794-461687D5-B3C8-4137-A092-B7BE7257B16DQ36159473-48001F46-A83D-4C25-B568-D9B52FEC6FA6Q36740688-DD043014-D5BE-4CD7-96F7-ED282D99C53DQ36850057-9E2DC4A7-55D5-48FB-9F5F-6A29114F094BQ38325612-22F07C08-F9EE-4080-8B7A-F078DD050AFFQ38809423-B9F37A48-856C-42E3-9832-3D99B77ED4EAQ39091511-8920AD07-D7A5-44BD-86B3-5A184EE90440Q45871914-53174E99-9769-426A-8B8C-4D99DC9C46E7Q55167558-61DA798F-90D5-4BDD-A01E-99AD54E80326Q57159243-901B3923-7733-4FD7-9873-7C45BBC56A6EQ57908994-8BBF618D-512A-4785-9B0D-22FE82F661DEQ58731093-3F028F20-D241-41F1-A33D-76D755F40EA3
P2860
Proteolytic cleavage of Ser52Pro variant transthyretin triggers its amyloid fibrillogenesis
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Proteolytic cleavage of Ser52P ...... rs its amyloid fibrillogenesis
@ast
Proteolytic cleavage of Ser52P ...... rs its amyloid fibrillogenesis
@en
Proteolytic cleavage of Ser52P ...... rs its amyloid fibrillogenesis
@nl
type
label
Proteolytic cleavage of Ser52P ...... rs its amyloid fibrillogenesis
@ast
Proteolytic cleavage of Ser52P ...... rs its amyloid fibrillogenesis
@en
Proteolytic cleavage of Ser52P ...... rs its amyloid fibrillogenesis
@nl
prefLabel
Proteolytic cleavage of Ser52P ...... rs its amyloid fibrillogenesis
@ast
Proteolytic cleavage of Ser52P ...... rs its amyloid fibrillogenesis
@en
Proteolytic cleavage of Ser52P ...... rs its amyloid fibrillogenesis
@nl
P2093
P2860
P50
P3181
P356
P1476
Proteolytic cleavage of Ser52P ...... rs its amyloid fibrillogenesis
@en
P2093
Annalisa Relini
Glenys A Tennent
Graham W Taylor
Innes R Clatworthy
Julian D Gillmore
Loredana Marchese
Mattia Porcari
Monica Stoppini
P Patrizia Mangione
Philip N Hawkins
P2860
P304
P3181
P356
10.1073/PNAS.1317488111
P407
P577
2014-01-28T00:00:00Z